Efrat Dotan, MD
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
Video: Efrat Dotan, MD
Assistant Program Director, Medical Oncology Fellowship Program
American Board of Internal Medicine,
Board certification in hematology and medical oncology
Early in my medical training I was drawn to the oncology field which combines compassionate patient care with cutting edge research. Once I completed my oncology training I elected to stay at Fox Chase Cancer Center where the combination of patient care and active research is a way of life. Furthermore, continued collaboration with the basic scientists at Fox Chase Cancer Center provides a perfect platform for development and testing of novel concepts in cancer management.
My research interests include evaluating new treatment targets and new treatment modalities that could potentially improve outcomes for patients with colorectal cancer and other gastrointestinal malignancies. In particular I am interested in the management and outcomes of elderly patients with cancer. Treatment of this patient population requires special consideration biologically, medically and socially. Due to the aging of our patient population, the field of geriatric oncology is rapidly growing. Continued research for identifying tumor characteristics that are specific to this population, and new treatment modalities that would be better tolerated by older individuals will have improve outcomes and quality of life of these patients.
MD, Technion, Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, cum laude 2002
Chief Resident, Internal Medicine, Lenox Hill Hospital, New York, NY, 2007;
Resident, Internal Medicine, Lenox Hill Hospital, New York, NY, 2006
Chief Fellow, Hematology-Oncology, Fox Chase Cancer Center, Philadelphia, PA
Honors and Awards
AMGEN fellowship grant 2009;
American College of Physician (ACP): Associate research competition award.
American Society of Clinical Oncology (ASCO);
International Society of Geriatric Oncology (SIOG);
Cancer and Aging Research Group (CARG);
Eastern Cooperative Oncology Group (ECOG);
American Medical Association (AMA)
Gastrointestinal malignancies new therapeutic targets; Geriatric Oncology